ROTE WILLIAM E. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
42
Insider Sells Sum
$2.15M

Insider Activity of ROTE WILLIAM E.

According to the SEC Form 4 filings, ROTE WILLIAM E., being in a position of

  1. Chief Research Officer at Travere Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 293357 shares for $16.43M,
    over all time since 2018-02-14, has bought 0 shares, and sold 395308 shares for $18.58M.

Biography of ROTE WILLIAM E.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $16,427,8306100

Comparison of Insiders on Amount of Buys and Sells

2026-09-16SaleTravere Therapeutics, Inc.
TVTX
Chief Research Officer
112,850
0.1211%
$63.33$7.15M-17.01%
2026-09-15SaleTravere Therapeutics, Inc.
TVTX
Chief Research Officer
96,198
0.103%
$62.25$5.99M-15.55%
2026-05-06SaleTravere Therapeutics, Inc.
TVTX
Chief Research Officer
2,763
0.0029%
$43.95$121,434+25.87%
2026-04-22SaleTravere Therapeutics, Inc.
TVTX
Chief Research Officer
9,100
0.0096%
$39.09$355,719+39.56%
2026-02-03SaleTravere Therapeutics, Inc.
TVTX
Chief Research Officer
12,446
0.0139%
$32.87$409,100+53.44%
2025-12-24SaleTravere Therapeutics, Inc.
TVTX
Chief Research Officer
60,000
0.0668%
$40.10$2.41M+14.65%
2025-05-05SaleTravere Therapeutics, Inc.
TVTX
Chief Research Officer
3,198
0.0035%
$21.05$67,318+29.47%
2025-02-12SaleTravere Therapeutics, Inc.
TVTX
SENIOR VICE PRESIDENT, R&D
5,200
0.0059%
$23.53$122,356-9.09%
2025-02-03SaleTravere Therapeutics, Inc.
TVTX
SENIOR VICE PRESIDENT, R&D
8,951
0.0099%
$19.78$177,051+4.3%
2025-01-22SaleTravere Therapeutics, Inc.
TVTX
SENIOR VICE PRESIDENT, R&D
2,437
0.0028%
$19.46$47,424+6.94%
2024-09-09SaleTravere Therapeutics, Inc.
TVTX
SENIOR VICE PRESIDENT, R&D
4,387
0.0051%
$11.52$50,538+37.44%
2024-02-01SaleTravere Therapeutics, Inc.
TVTX
SENIOR VICE PRESIDENT, R&D
4,764
0.0062%
$8.71$41,495+5.29%
2024-01-23SaleTravere Therapeutics, Inc.
TVTX
SENIOR VICE PRESIDENT, R&D
2,062
0.0027%
$8.96$18,476-3.12%
2023-09-05SaleTravere Therapeutics, Inc.
TVTX
Senior Vice President, R&D
1,815
0.0025%
$14.71$26,699-43.8%
2023-05-10SaleTravere Therapeutics, Inc.
TVTX
Senior Vice President, R&D
825
0.0012%
$16.59$13,687-46.81%
2023-02-01SaleTravere Therapeutics, Inc.
TVTX
Senior Vice President, R&D
2,590
0.0038%
$22.25$57,628-30.47%
2023-01-24SaleTravere Therapeutics, Inc.
TVTX
Senior Vice President, R&D
2,062
0.003%
$21.50$44,333-28.72%
2022-05-11SaleTravere Therapeutics, Inc.
TVTX
Senior Vice President, R&D
813
0.0013%
$21.52$17,493+3.51%
2022-01-31SaleTravere Therapeutics, Inc.
TVTX
Senior Vice President, R&D
1,125
0.0018%
$27.40$30,825-11.82%
2022-01-24SaleTravere Therapeutics, Inc.
TVTX
Senior Vice President, R&D
1,875
0.0029%
$24.98$46,838-5.13%
Total: 48
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.